Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing Pharmacology
Notes
SULFONYLUREAS & MEGLITINIDES | ||
DRUG NAME | First generation: tolbutamide, tolazamide, chlorpropamide Second generation: glimepiride (Amaryl), glipizide (Glucotrol), glyburide (Glynase) *High Alert Medications* | repaglinide, nateglinide *High Alert Medications* |
CLASS | Sulfonylureas | Meglitinides |
MECHANISM OF ACTION | Inhibit ATP-sensitive K+ channels on pancreatic beta cells → increase insulin secretion → decrease blood glucose levels | |
INDICATIONS | Type 2 diabetes mellitus | |
ROUTE(S) OF ADMINISTRATION | PO | |
SIDE EFFECTS |
| |
CONTRAINDICATIONS AND CAUTIONS |
|
NURSING CONSIDERATIONS: SULFONYLUREAS & MEGLITINIDES | ||
ASSESSMENT AND MONITORING | Sulfonylureas and meglitinides Assess
Monitor
| |
CLIENT EDUCATION | Sulfonylureas and meglitinides
|
Sources
- "Focus on Nursing Pharmacology" LWW (2019)
- "Pharmacology" Elsevier Health Sciences (2014)
- "Mosby's 2021 Nursing Drug Reference" Mosby (2020)
- "Saunders Comprehensive Review for the NCLEX-RN Examination" Saunders (2016)